US FDA targets “lawful pathways” for CBD marketing, warns about “unfounded” health claims

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

02 Jun 2020 --- Consumers continue to be at risk of imported adulterated supplements, with the US Natural Products Association (NPA) calling for a two-pronged public-private... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

20 May 2020 --- More than a year has passed since cannabidiol (CBD) was classified as a novel food in January 2019, yet the regulatory situation regarding its safety and... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

14 May 2020 --- Consumers continue to face a torrent of information – true and false alike – meaning it is often coming down to advertising watchdogs to decipher fact... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

14 May 2020 --- Gencor’s palmitoylethanolamide (PEA) ingredient, called Levagen+, has demonstrated almost double absorption potential when administered via Pharmako... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

11 May 2020 --- Some US states are going rogue in their regulation of hemp and cannabidiol (CBD) products as the Food and Drug Administration (FDA) continues to stall on providing... Read More

trans